Pancreas Volume 47, Number 3, March 2018 Letters to the Editor multicenter survey. Endoscopy.2007;39: 4 cases of pancreatitis (1.98%). In these P = 0.01) (Fig. 1). The statistical hetero- 613–615. cases, the admission length of stay was 4, geneity was moderate with I of 58% 7, 14, and 15 days. This subgroup of patients (P = 0.02). 7. Möschler O, May A, Müller MK, et al. heterogeneity with pancreatitis had a significantly longer Theoretically, metformin was found Complications in and performance of inpatient stay than that noted by Wadhwa double-balloon enteroscopy (DBE): results to have antineoplastic properties through et al. Therefore, perhaps further study is re- from a large prospective DBE database in several mechanisms in in vitro studies. Germany. Endoscopy. 2011;43:484–489. quired in understanding the length of stay in Pancreatic cancer cells are supposedly hospital and therefore cost by subdividing stimulated by insulin-like growth factor 8. Jovanovic I, Vormbrock K, Zimmermann L, pancreatitis by etiology. et al. Therapeutic double-balloon enteroscopy: 1(IGF-1). Whole body production and In conclusion, DBE is an iatrogenic a binational, three-center experience. Dig Dis. sensitivity of IGF-1 are increased by cause of acute pancreatitis. It is of interest 2011;29(suppl 1):27–31. hyperinsulinemic states. Metformin decreases that
Pancreas – Wolters Kluwer Health
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera